Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons
US9950033B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 29, 2012 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Feb 29, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.